The PE Ratio as of November 2024 (TTM) for Kala Pharmaceuticals, Inc. (KALA) is -0.58

According to Kala Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.58. This represents a change of 0.53% compared to the average of -0.58 of the last 4 quarters.

Kala Pharmaceuticals, Inc. (KALA) Historical PE Ratio (quarterly & annually)

How has KALA PE Ratio performed in the past?

The mean historical PE Ratio of Kala Pharmaceuticals, Inc. over the last ten years is -30.09. The current -0.58 PE Ratio has changed 92.77% with respect to the historical average. Over the past ten years (40 quarters), KALA's PE Ratio was at its highest in in the September 2022 quarter at 0.14. The PE Ratio was at its lowest in in the September 2017 quarter at -10.12.

Kala Pharmaceuticals, Inc. (KALA) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Kala Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Kala Pharmaceuticals, Inc. (KALA) Average PE Ratio

How has KALA PE Ratio performed in the past?

The current PE Ratio of Kala Pharmaceuticals, Inc. (KALA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Kala Pharmaceuticals, Inc. (KALA) PE Ratio vs. Peers

How is KALA’s PE Ratio compared to its peers?

Kala Pharmaceuticals, Inc.’s PE Ratio is less than Mallinckrodt plc (-0.04), less than Lifecore Biomedical, Inc. (34.50), greater than Lucy Scientific Discovery Inc. (-1.23), greater than Alimera Sciences, Inc. (-20.50), greater than Adamis Pharmaceuticals Corporation (-0.67), less than Shuttle Pharmaceuticals Holdings, Inc. (-0.23), greater than Journey Medical Corporation (-6.01), less than Akanda Corp. (-0.04), greater than Organogenesis Holdings Inc. (-72.75), less than Biofrontera Inc. (-0.39), less than Guardion Health Sciences, Inc. (0.65), greater than China Pharma Holdings, Inc. (-0.70), less than Alkermes plc (14.10), less than Neurocrine Biosciences, Inc. (32.92), greater than Intra-Cellular Therapies, Inc. (-104.94), greater than Deciphera Pharmaceuticals, Inc. (-11.74), less than Dynavax Technologies Corporation (79.53),

Build a custom stock screener for Kala Pharmaceuticals, Inc. (KALA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kala Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kala Pharmaceuticals, Inc. (KALA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kala Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.